Nilotinib: A Novel, Selective Tyrosine Kinase Inhibitor-Reference-Cited by-同舟云学术

Nilotinib: A Novel, Selective Tyrosine Kinase Inhibitor

Published:2011-04 Issue: Volume:38 Page:S3-S9
ISSN:0093-7754
Container-title:Seminars in Oncology
language:en
Short-container-title:Seminars in Oncology

Author:

Blay Jean-Yves,von Mehren Margaret

Funder

Novartis Pharmaceuticals Corporation

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference52 articles.

1. Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells;Druker;Nat Med,1996

2. Signaling networks associated with BCR-ABL-dependent transformation;Hazlehurst;Cancer Control,2009

3. Structural mechanism for STI-571 inhibition of abelson tyrosine kinase;Schindler;Science,2000

4. Abl protein-tyrosine kinase inhibitor STI571 inhibits in vitro signal transduction mediated by c-kit and platelet-derived growth factor receptors;Buchdunger;J Pharmacol Exp Ther,2000

5. Imatinib therapy in chronic myelogenous leukemia: strategies to avoid and overcome resistance;Hochhaus;Leukemia,2004

Cited by 118 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Side Chain Investigation of Imidazopyridazine as a Hinge Binder for Targeting Actionable Mutations of RET Kinase;ACS Medicinal Chemistry Letters;2024-09-03

2. The pro-tumoral and anti-tumoral roles of EphA4 on T regulatory cells and tumor associated macrophages during HNSCC tumor progression;2024-08-13

3. Integrative Analysis of Multi-Omics Data to Identify Deregulated Molecular Pathways and Druggable Targets in Chronic Lymphocytic Leukemia;Journal of Personalized Medicine;2024-08-06

4. A Quality by Design (QbD) driven gradient high performance liquid chromatography method development for the simultaneous estimation of dasatinib and nilotinib in lipid nanocarriers;Journal of Chromatography B;2024-08

5. Current Progress on the Influence Human Genetics Has on the Efficacy of Tyrosine Kinase Inhibitors Used to Treat Chronic Myeloid Leukemia;Cureus;2024-03-20